글로벌 Fanconi 빈혈 치료 시장 – 2029년까지의 산업 동향 및 예측

글로벌 파코니 빈혈 치료 시장 분석 및 규모

최근 몇 년 동안, 판코니 빈혈 치료 시장은 빠르게 성장할 것으로 예상됩니다. 판코니 빈혈 환자는 골수에서 혈액을 형성하는 세포의 악성 종양인 급성 골수성 백혈병(AML)이나 두경부 , 피부, 위장관계 또는 생식기 암을 앓을 가능성이 더 높습니다. 이로 인해 판코니 빈혈의 표준 치료에 대한 수요가 증가하고, 따라서 시장에 판코니 빈혈 치료가 도입될 것입니다.  

• 파코니 빈혈은 상염색체 열성 질환으로, 조혈 기능 장애, 선천적 이상, 환자에서 고형 종양과 급성 골수성 백혈병이 상당히 많이 발생합니다. 골수에 영향을 미치는 드문 질환으로, 가족을 통해 유전됩니다(유전). 파코니 빈혈은 호흡 곤란, 잦은 비강 출혈, 피로, 반복적인 바이러스 감염, 감기, 낮은 키, 성장 부진 등이 모두 파코니 빈혈의 징후입니다.
• Data Bridge Market Research에 따르면, 판코니빈혈 치료 시장 규모는 2021년에 5억 2,000만 달러에 달했으며, 2029년까지 8억 1,022만 달러에 도달할 것으로 예상되어 2022년부터 2029년까지의 예측 기간 동안 연평균 성장률이 5.70%가 될 것으로 예상됩니다.

파코니 빈혈 치료제 시장 동향

운전자

• 혈액질환의 유병률이 높다

혈액 질환 유병률의 증가는 시장 성장률 확대로 이어질 주요 원동력으로 작용할 것입니다. 유전자 돌연변이는 혈액 질환 발병 가능성을 높이기 때문에, 판코니 빈혈 치료 시장이 성장할 것으로 예상됩니다.

• 의료 인프라에 대한 투자 증가

파코니빈혈 치료 시장의 성장률에 영향을 미치는 또 다른 중요한 요인은 의료 서비스 지출이 증가하고 있다는 점인데, 이는 인프라 개선에 도움이 됩니다.

또한, 공공 및 민간 기관에서 인식을 확산하기 위한 이니셔티브가 증가하고 노인 인구가 늘어나는 것이 판코니 빈혈 치료 시장을 확대할 요인입니다. 끊임없이 변화하는 라이프스타일과 높은 가처분 소득과 같은 다른 요인은 판코니 빈혈 치료 시장의 성장률에 긍정적인 영향을 미칠 것입니다. 또한, 조기 유전 상담의 채택이 증가하면 판코니 빈혈 치료 시장이 확대될 것입니다. 

기회

• Rise in the investments and research funding for fanconi anemia treatment will flourish the growth rate

Moreover, the rise in level of investments and funds for research and development activities will boost new opportunities for the market's growth rate.

Also, surging number of strategic partnership with various public and private organizations and advancement in medical technology will provide beneficial opportunities for the fanconi anemia treatment market in the forecast period of 2022-2029.

Restraints/Challenges Global Fanconi Anemia Treatment Market

However, high cost associated with the available treatment and lack of infrastructure in low-income countries will impede the growth rate of fanconi anemia treatment market. Additionally, complications linked with this condition will hinder the fanconi anemia treatment market growth. The lack of standard treatment for this disease and less patient awareness will further challenge the market in the forecast period mentioned above.

This fanconi anemia treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on fanconi anemia treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Fanconi anemia treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Fanconi Anemia Treatment Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. Due to the financial crisis and the delay in specialty healthcare delivery, while prioritizing COVID-19-related treatments, healthcare systems around the world have been severely disrupted in the aftermath of the coronavirus pandemic. Patients were unable to see their controls for various reasons, including difficulty accessing a doctor, fear of infection transmission, inability to continue therapies and essential procedures due to pandemic restrictions. Such considerations may have a negative impact on the market of fanconi anemia treatment in recent months.

Recent Development

• In March 2020, Forty Seven and Rocket Pharmaceuticals had announced research collaboration for fanconi anemia. This therapeutic regimen will be tested in the first partnership in Fanconi Anemia (FA). This hereditary condition inhibits patients' ability to generate blood cells and is linked to an elevated risk of leukaemia and other neoplasms.

Global Fanconi Anemia Treatment Market Scope

The fanconi anemia treatment market is segmented on the basis of treatment, diagnosis, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Blood and Bone Marrow Transplant
• Blood Transfusion
• Medication
• Others

On the basis of treatment, the fanconi anemia treatment market is segmented into blood and bone marrow transplant, blood transfusion, medication, and others. The medication segment is further segmented into antibiotics, immunosuppressant, antivirals and bone marrow stimulants and others.

Diagnosis

• Hearing Test
• Bone Marrow Biopsy
• Complete Blood Count (CBC)
• Developmental Tests
• Imaging Tests
• Others

On the basis of diagnosis, the fanconi anemia treatment market is segmented into hearing test, bone marrow biopsy, complete blood count (CBC), developmental tests, imaging tests and others. Imaging tests segment is further segmented into computed tomography (CT) scans, magnetic resonance imaging (MRI) scan, ultrasound and others.

Dosage

• Injection
• Tablets
• Others

On the basis of dosage, the fanconi anemia treatment market is segmented into injection, tablets, and others.

Route of Administration

• Oral
• Parenteral
• Others

On the basis of route of administration, the fanconi anemia treatment market is segmented into oral, parenteral and others.

End-Users

• Clinic
• Hospital
• Others

On the basis of end-users, the fanconi anemia treatment market is segmented into clinic, hospital and others.

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

The fanconi anemia treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Fanconi Anemia Treatment Market Regional Analysis/Insights

The fanconi anemia treatment market is analysed and market size insights and trends are provided by country, treatment, diagnosis, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the fanconi anemia treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the fanconi anemia treatment market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and well-developed healthcare infrastructure in this region.

Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the increasing patient pool, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Fanconi Anemia Treatment Market Share Analysis

The fanconi anemia treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to fanconi anemia treatment market.

판코니빈혈 치료 시장의 주요 기업으로는 Allergan, Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc, Melinta Therapeutics LLC, Basilea Pharmaceutica Ltd., Tetraphase Pharmaceuticals, Paratek Pharmaceuticals, Inc., Nabriva Therapeutics plc, Spero Therapeutics, Abbott, F. Hoffmann-La Roche Ltd., Mylan NV, Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Bayer AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, SHIONOGI & Co., Ltd., AbbVie Inc., Eli Lilly and Company 등이 있습니다.

SKU-52892